Clinical Trials Browser

Multiple Sclerosis, Myasthenia Gravis, Recurrence, Autoimmune Diseases of the Nervous System, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating

NCT06318871 2026-05-11

Memory-like Natural Killer (NK) Cell Therapy in Patients With Renal Cell Carcinoma or Urothelial Carcinoma

Phase EARLY_PHASE1 Active not recruiting

5 enrolled

Genitourinary

Carcinoma, Renal Cell, Carcinoma, Transitional Cell

Clinical Trials

Hyperpolarized Carbon-13 Alpha-ketoglutarate Imaging in IDH Mutant Glioma

A Clinical Study Evaluating the Safety and Efficacy of GT801 Injection in Adult Patients With Relapsed/Refractory CD19-positive B-cell Hematologic Malignancies and Autoimmune Hemolytic Anemia

DOTA-STR-17126

Chemical-Shift-Encoded MRI for Active Bone Marrow Dosimetry in Radiopharmaceutical Therapy

Study of a Shortened Radiation Therapy Schedule in People With Breast Cancer

Pembrolizumab, INCB081776, and Radiation Therapy for Head and Neck Squamous Cell Carcinoma

CDH17 CAR-T Therapy in Advanced Malignant Solid Tumors

Smoking Cessation Treatment for Head & Neck Cancer Patients

Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies

Gemcitabine Plus Ascorbate for Sarcoma in Adults (Pilot)

Fecal Microbial Transplants for the Treatment of Pancreatic Cancer

PHL Treatment in Pancreatic Cancer

Study of CBL0137 in Combination With Ipilimumab and Nivolumab Therapy in Melanoma

A Clinical Study Evaluating the Safety and Efficacy of Local Injection of ACT#001 Chimeric Antigen Receptor T Cells in the Treatment of Castration-Resistant Prostate Cancer

Active Surveillance and Chemotherapy Before Surgery in Treating Participants With Stage II-III Rectal Cancer

PET/MRI Scan for the Evaluation of Resectable Stage IA1-IB3 Cervical Cancer

A Pilot "Window-3" Study of Acalabrutinib Plus Rituximab Followed by Brexucabtagene Autoleucel Therapy in Patients With Previously Untreated High-risk Mantle Cell Lymphoma

Safety and Efficacy of NK510 to Treat NSCLC

9vHPV-BCG

Nano-X IG

A IIT Study of 177Lu-DOTA-SNA040

Phase IIT Trial of SNA009

Preliminary Trial of SNA014 for Pancreatic Cancer

5-Azacitidine and Decitabine Epigenetic Therapy for Myeloid Malignancies

Drug Screening Using IMD in Bladder Cancer

AMT-676 in Patients With Advanced Solid Tumors

SCC

ASPIRED-XT: ASPirin Intervention for the REDuction of Colorectal Cancer Risk -EXTension

A Phase I Study on Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics and Preliminary Efficacy of SXRN Plasmid DNA Technique in Patients With Advanced Solid Tumors

Clinical Application of CAIX-Targeted PET Imaging in Tumors

A Preliminary Efficacy of SNA028 in Patients With Advanced Colorectal Cancer Positive for GPA33

Study of Sonodynamic Therapy in Participants With Recurrent High-Grade Glioma

Study of Pamiparib in Newly Diagnosed and rGBM

Radiosurgery Before Surgery for the Treatment of Brain Metastases

Superselective Intra-arterial Cerebral Infusion of Temsirolimus in HGG

Neoadjuvant Dupilumab, Pembrolizumab, Paclitaxel, and Carboplatin in Locally Advanced Triple Negative Breast Cancer

BGB-58067 in Newly Diagnosed Glioblastoma Patients With MTAP-Deleted Tumors

Administration of Repurposed Ketoconazole in Glioma Patients

In Vivo BCMA/GPRC5D Tandem Dual CAR-T Therapy for Relapsed/Refractory Plasma Cell Neoplasms

Efficacy and Safety of Neoadjuvant Cadonilimab Plus High-Dose Recombinant Human Interferon α1b in Stage III/IV Melanoma.

Exploratory Clinical Study of ¹⁷⁷Lu-CTR-FAPI in Patients With Metastatic Solid Tumors

Vitamin D in Patients With Stage I-III Colon Cancer or Resectable Colon Cancer Liver Metastases

Testing the Response to the Anti-cancer Drug, Triapine, in Uterine Cancers Using Markers From the Tissue at the Time of Hysterectomy

Botensilimab, Balstilimab, and SBRT in Colorectal Cancer

A Platform Study of In Vivo CAR-T for Treating Advanced Malignant Tumors Based on Target Screening

An Exploratory Study of Personalized Cancer Vaccine in Adjuvant Therapy of Solid Tumors

Evaluation of GI001 for Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Phase I Master Protocol of Novel Combination Therapy for Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma

CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases

Memory-like Natural Killer (NK) Cell Therapy in Patients With Renal Cell Carcinoma or Urothelial Carcinoma